New gel aims to fade melasma with fewer side effects
NCT ID NCT07530016
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early study tests a new gel for melasma, a skin condition causing dark patches on the face. The gel combines three ingredients to lighten spots, reduce inflammation, and help absorption. Ten women aged 18-50 will apply the gel for 12 weeks to see if it improves their skin with fewer side effects than current treatments.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LAUROCAPRAM are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a simple drug cut bleeding risk in weight-loss surgery?
- Can a simple pill make melasma creams work better?
- Can a two-acid cream fade stubborn melasma?
- Can sunscreen do more than protect? study tests if it fades dark spots
- New cream trio aims to outshine standard melasma treatment
- Can sound waves clear up skin? new trial tests ultrasound for pigment and rosacea